Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps University of Marburg, Baldinger Str., 35043, Marburg, Germany.
Herz. 2023 Jun;48(3):243-246. doi: 10.1007/s00059-023-05177-3. Epub 2023 Apr 23.
For the past 3 years, our daily lives have been largely dictated by the coronavirus disease 2019 (COVID-19) pandemic. In many people, this infectious disease leads to long-lasting symptoms, which can vary greatly in form and intensity between individuals. This report describes the case of a young patient who had no health restrictions until she came into contact with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As part of a post-COVID syndrome, she not only temporarily lost her ability to work, but was also no longer able to manage her daily life independently. A crucial therapeutic approach, in this case, was the use of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.) apheresis.
在过去的 3 年中，我们的日常生活在很大程度上受到了 2019 年冠状病毒病（COVID-19）大流行的影响。在许多人身上，这种传染病会导致长期的症状，这些症状在个体之间的表现形式和强度差异很大。本报告描述了一位年轻患者的病例，她在接触到严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）之前没有任何健康限制。作为 COVID-19 后综合征的一部分，她不仅暂时丧失了工作能力，而且也无法再独立管理日常生活。在这种情况下，一个关键的治疗方法是使用肝素诱导的体外 LDL/纤维蛋白原沉淀（H.E.L.P.）血浆分离术。
